FIELD: medicine.
SUBSTANCE: invention relates to a new biologically active compound 9-aminium-3,3-dimethyl-3,4-dihydroacridin-1(2H)-one 2-hydroxy-butanediovate and its use as a medicinal product with antitumor and antimetastatic activity against melanoma and adenocarcinoma of the breast.
EFFECT: obtaining a new 9-aminoacridone derivative with antitumor and antimetastatic activity.
2 cl, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
2-AMINOCHROMEN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY; PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2704262C1 |
2-AMINIUM-7-(DIETHYLAMINO)-4-(4-METHOXIBENZO[D][1,3]DIOXOL-5-YL)-4H-CHROMEN-3-CARBONITRILE N-ACETYLAMINOETHANOAT HAVING ANTITUMOR ACTIVITY | 2018 |
|
RU2674987C1 |
AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
2,2-DIMETHYL-1,2-DIHYDRO-5-(N-MORPHOLINE)-8-CHLOR OR PHENYLHYDRAZINO-4H-PIRANO[4′,3′:4,5]PYRIDO[2,3-B]THIENO[3,2-D]-9,10,11-TRIAZINES HAVING ANTITUMOR ACTION | 1988 |
|
SU1570274A1 |
DRUG WITH ANTIPROLIFERATIVE AND ANTIMETASTATIC EFFECTS AGAINST LEWIS LUNG CARCINOMA WHEN INJECTED INTRAPERITONEALLY | 2022 |
|
RU2792144C1 |
ANTITUMOUR AGENT, RELATED TO GROUP OF METAL-ORGANIC DERIVATIVES OF POLYACRYLIC ACID | 2008 |
|
RU2372091C1 |
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
ANTINEOPLASTIC AGENT | 2016 |
|
RU2623034C1 |
METHOD OF COMBINATION THERAPY OF B16 MELANOMA IN METRONOMIC MODE IN EXPERIMENT | 2022 |
|
RU2792561C1 |
Authors
Dates
2023-12-28—Published
2021-12-22—Filed